In the advancing frontier of synthetic biology, nucleotide modifications have emerged as a powerful tool to enhance the performance of reporter mRNAs, such as those encoding enhanced green fluorescent protein (eGFP). These modifications not only improve mRNA stability but also boost translation efficiency, thereby amplifying the reporter signal.

By incorporating modified nucleotides, such as pseudouridine and 5-methoxycarbonyl methyl uridine, into the eGFP reporter mRNA sequence, researchers can significantly extend its half-life within cells. These chemical alterations mimic natural RNA modifications, reducing the immune response triggered by foreign RNA and enabling longer-lasting expression of eGFP.

Moreover, nucleotide modifications can fine-tune eGFP reporter mRNAs' translation rate. By adjusting the sequence context and the types of modified nucleotides, researchers can optimize the ribosome flow, ensuring smoother and more efficient protein synthesis.

In conclusion, nucleotide modifications are a pivotal advancement in synthetic mRNAs, particularly for eGFP reporter systems. They offer a means to bolster mRNA stability, enhance translation efficiency, and ultimately amplify the reporter signal, making them indispensable for precise and reliable gene expression studies.

Yaohai Bio-Pharma is the first and largest biologics dedicated to microbial expression system CRDMO in Greater China. We are committed to meeting our global customers' clinical and commercial needs for biological medicines, vaccines, and diagnostics for human and veterinary use.

كما أننا نبحث بنشاط عن شركاء عالميين مؤسسيين أو فرديين. نحن نقدم التعويض الأكثر تنافسية في هذه الصناعة. إذا كان لديك أي أسئلة، فلا تتردد في الاتصال بنا: [email protected]